Cardiovascular Risk With and Without Antihypertensive Drug Treatment in the Japanese General Population
Authors:
- Kei AsayamaKAKei Asayama
- Michihiro SatohMSMichihiro Satoh
- Takayoshi OhkuboTOTakayoshi Ohkubo
- Sin-Ya NagasawaSNSin-Ya Nagasawa
- Takeo NakayamaTNTakeo Nakayama
- Katsuyuki MiuraKMKatsuyuki Miura
- Tomonori OkamuraTomonori Okamura
- 1 June 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 63 (6) , 1189-1197
Abstract
To evaluate the cardiovascular mortality risk in association with blood pressure level among people with and without antihypertensive treatment, we performed the participant-level meta-analysis that included 39 705 Japanese from 6 cohorts (58.4% women; mean age, 60.1 years; 20.4% treated). Multivariable-adjusted Cox models were used to analyze the risk of cardiovascular mortality and its subtypes among 6 blood pressure levels according to recent guidelines, optimal to Grade 3 hypertension, and the usage of antihypertensive medication at baseline. During median 10.0 years of follow-up, there were 2032 cardiovascular deaths (5.1 per 1000 person-years), of which 410 deaths were coronary heart disease, 371 were heart failure, and 903 deaths were stroke. Treated participants had significantly higher risk for cardiovascular mortality (hazard ratios, 1.50; 95% confidence intervals, 1.36–1.66), coronary heart disease (hazard ratios, 1.53; confidence intervals, 1.23–1.90), heart failure (hazard ratios, 1.39; confidence intervals, 1.09–1.76), and stroke (hazard ratios, 1.48; confidence intervals, 1.28–1.72) compared with untreated people. Among untreated participants, the risks increased linearly with an increment of blood pressure category ( P ≤0.011). The risk increments per blood pressure category were higher in young participants (P ≤0.026). Among treated participants, the significant linear association was also observed for cardiovascular mortality ( P =0.0003), whereas no stepwise increase in stroke death was observed ( P =0.19). The risks of cardiovascular mortality were ≈1.5-fold high in participants under antihypertensive medication. More attention should be paid to the residual cardiovascular risks in treated patients.Keywords
This publication has 43 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- Relation Between Serum Total Cholesterol Level and Cardiovascular Disease Stratified by Sex and Age Group: A Pooled Analysis of 65 594 Individuals From 10 Cohort Studies in JapanJournal of the American Heart Association, 2012
- Influence of Smoking Combined with Another Risk Factor on the Risk of Mortality from Coronary Heart Disease and Stroke: Pooled Analysis of 10 Japanese Cohort StudiesCerebrovascular Diseases, 2012
- Blood Pressure and the Risk of Stroke, Cardiovascular Disease, and All-Cause Mortality Among Japanese: The JPHC StudyAmerican Journal of Hypertension, 2009
- Relation of Blood Pressure and All-Cause Mortality in 180 000 Japanese ParticipantsHypertension, 2008
- Blood Pressure Control and Risk of StrokeStroke, 2005
- Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general populationAmerican Heart Journal, 2004
- Prevalence of Asymptomatic Carotid Atherosclerotic Lesions Detected by High-Resolution Ultrasonography and Its Relation to Cardiovascular Risk Factors in the General Population of a Japanese CityStroke, 1997
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987